Tom Brady Teams with Digital Health Firm eMed to Expand GLP-1 Weight Loss Medication Access

Tom Brady teams with digital health firm eMed to expand GLP-1 weight loss medication access

As GLP-1 weight loss medications continue to surge in popularity, NFL legend Tom Brady is getting in on the action, using his wellness brand to "democratize" the health care system in a way the world has "never seen."The seven-time Super Bowl champion has teamed up with eMed, a digital health company managing sustainable ways to offer GLP-1 drugs while helping employers reduce health insurance claims."There's an epidemic in America, the disease …

Financial News Network - Tom Brady teams with digital health firm eMed to expand GLP-1 weight loss medication access

NFL legend Tom Brady partners with eMed to tackle the obesity epidemic by making GLP-1 weight-loss medications accessible through employer health benefits.Read More …